Marker Therapeutics (MRKR) Receivables - Accured (2018 - 2020)
Marker Therapeutics (MRKR) reported Receivables - Accured of $559.0 for Q4 2020, down 99.01% year-over-year from $56189.0 in Q1 2020, and up 314.07% quarter-over-quarter from $135.0 in Q3 2020.
Marker Therapeutics (MRKR) Receivables - Accured (2018 - 2020) Analysis & Trends
Marker Therapeutics (MRKR) has 3 years of Receivables - Accured data on file, last reported at $559.0 in Q4 2020.
- Receivables - Accured for Q4 2020 came in at $559.0, down 99.01% year-over-year; the trailing twelve-month figure through Dec 2020 was $559.0 (down 99.01% YoY), and the FY2020 annual result was $559.0, down 99.01% from the prior year.
- Receivables - Accured improved to $559.0 in Q4 2020 per MRKR's latest filing, from $135.0 in the prior quarter.
- Over five years, Receivables - Accured peaked at $112200.0 in Q1 2019 and troughed at $135.0 in Q3 2020.
- A 3-year average of $53511.6 and a median of $56189.0 in 2019 frame the typical range for Receivables - Accured.
- The sharpest annual moves came in 2019 and 2020: Receivables - Accured plunged 48.06% in 2019, then slumped 99.83% in 2020.
- A 3-year view of Receivables - Accured shows it stood at $108177.0 in 2018, then sank by 48.06% to $56189.0 in 2019, then tumbled by 99.01% to $559.0 in 2020.
- Business Quant data shows MRKR's Receivables - Accured at $559.0 in Q4 2020, $135.0 in Q3 2020, and $3440.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 559.00 |
| Dec 31, 2020 | 559.00 |
| Sep 30, 2020 | 135.00 |
| Sep 30, 2020 | 135.00 |
| Jun 30, 2020 | 3,440.00 |
| Jun 30, 2020 | 3,440.00 |
| Mar 31, 2020 | 24,605.00 |
| Mar 31, 2020 | 24,605.00 |
| Dec 31, 2019 | 56,189.00 |
| Dec 31, 2019 | 56,189.00 |
| Sep 30, 2019 | 78,145.00 |
| Sep 30, 2019 | 78,145.00 |
| Jun 30, 2019 | 98,154.00 |
| Jun 30, 2019 | 98,154.00 |
| Mar 31, 2019 | 112,200.00 |
| Mar 31, 2019 | 112,200.00 |
| Dec 31, 2018 | 108,177.00 |
| Dec 31, 2018 | 108,177.00 |